Although the vast majority of the top-selling biopharmaceutical drugs are monoclonal antibodies, BioPharmaSpec routinely supports the characterization of other recombinant proteins.

Regulatory guideline documents recommend that the following are assessed:

Structural Characterization

Physicochemical Characterization